Mevion Medical Systems Stock
Mevion Medical Systems develops radiation therapies for the treatment of cancer.
Sign up today and learn more about Mevion Medical Systems Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Mevion Medical Systems Stock
Mevion Medical Systems, Inc. (formerly Still River Systems, Inc.) is a radiation therapy company dedicated to advancing the treatment of cancer. As the pioneering developer of modern proton therapy systems, Mevion provides innovative, safe, and effective solutions by transforming advances in medical technology and science into practical clinical reality. Mevion’s flagship product, the MEVION S250 Proton Therapy System, is designed to preserve all of the treatment benefits of traditional proton therapy systems while removing the obstacles of size, cost, and complexity. Realizing this vision, Mevion has forever changed the economics and accessibility of proton therapy worldwide. Founded in 2004, Mevion is a privately held company headquartered in the Boston metropolitan area with international offices in the United Kingdom and Japan.
Funding History
| October 2007 | $6.9M |
|---|---|
| April 2008 | $10.0M |
| January 2009 | $33.0M |
| March 2011 | $11.5M |
| January 2012 | $45.0M |
| January 2012 | $25.0M |
| June 2013 | $55.0M |
| August 2014 | $200M |
| August 2015 | $58.8M |
| June 2018 | $150M |
Management
Vice President of Regulatory and Quality Assurance
Thomas Faris
Vice President of Engineering
Mark Jones
Vice President Clinical Systems
Stanley Rosenthal
President and Chief Executive Officer
Joseph K. Jachinowski
Chairman
Robert Wilson
Chief Executive Officer
Tina Tianning Yu
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
